The Phase-2b study is a randomized, double-blind, placebo-controlled trial that will enroll approximately 195 patients across 35 sites in the USA
This collaboration aims to combine Molcure’s cutting-edge AI technology with Boehringer Ingelheim’s extensive expertise in drug discovery
Drug Hunter is already relied upon by researchers at more than 200 leading organizations, including Eli Lilly, Biogen, Merck KGaA, Isomorphic Labs, Deerfield Management
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
The company's decision to withdraw the MAA was due to the timing of the availability of Chemistry Manufacturing and Controls
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun
Multi-year collaboration focuses on development of biodegradable antimicrobial peptides with broad application possibilities in the areas of skin care and healthcare
Ibara will drive AI-powered clinical research innovation
Commercial terms include research funding and milestones and/or royalty payments to Evotec based on the success of the program
Subscribe To Our Newsletter & Stay Updated
